Role of microRNA-223-3p in Papillary Thyroid Carcinoma
Author Information
Author(s): Pan Xinghe, Liu Junliang, Zhang Yitong, Sun Chenglin, Li You, Guo Hongpeng
Primary Institution: Central Hospital Affiliated to Shenyang Medical College
Hypothesis
This study investigates the dysregulated expression of microRNA-223-3p in advanced PTC and its potential as a diagnostic biomarker.
Conclusion
MicroRNA-223-3p significantly promotes cell proliferation, invasion, and migration in papillary thyroid carcinoma by targeting NF2.
Supporting Evidence
- MicroRNA-223-3p was significantly upregulated in PTC tissues compared to adjacent healthy tissues.
- Patients with higher microRNA-223-3p levels had more advanced stages of PTC.
- Transfection of microRNA-223-3p mimics increased cell proliferation and invasion in PTC cell lines.
- NF2 was identified as a direct target of microRNA-223-3p, linking it to PTC progression.
- Animal studies showed that microRNA-223-3p promotes tumor growth in vivo.
Takeaway
This study found that a tiny molecule called microRNA-223-3p helps cancer cells grow and spread in a type of thyroid cancer.
Methodology
The study involved collecting tissue samples from patients, cell culture, qRT-PCR, CCK-8 assays, flow cytometry, transwell assays, and immunoblotting.
Limitations
The study had a relatively limited sample size and focused primarily on the interaction between microRNA-223-3p and NF2.
Participant Demographics
Patients diagnosed with papillary thyroid carcinoma.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website